Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Article in English | IMSEAR | ID: sea-135778

ABSTRACT

Ion channels present in the plasma membrane and intracellular organelles of all cells, play an important role in maintaining cellular integrity, smooth muscle contraction, secretion of hormones and neurotransmitters. Among the ion channels, potassium channels (K+) are the most abundant having important role in cardiac repolarization, smooth muscle relaxation and insulin release. These are also involved in the regulation of physiological functions like gastrointestinal peristalsis. These channels are the most diverse of all ion channels and are coded by at least 75 genes. Moreover, these have different subunits which co-assemble to form diverse functional channels. Abnormalities in K+ channels are associated with diseases like long QT syndrome, Anderson Tawil syndrome, epilepsy, type 2 diabetes mellitus, etc. A number of naturally occurring as well as synthetic compounds have been identified that modulate the opening and closure of KATP Channels. Some of the currently available K+ channel modulators like sulphonylureas, minoxidil, amiodarone, etc. lack tissue selectivity and have adverse effects. Hence, the success of KATP channel modulators depend on their tissue selectivity. Molecular level studies are needed to understand the type of K+ channels as this can lead to the development of newer drugs with tissue selectivity for various diseases.


Subject(s)
Animals , Brain/physiology , Diabetes Mellitus, Type 2/physiopathology , Heart/physiology , Heart Diseases/physiopathology , Humans , Potassium Channel Blockers/therapeutic use , Potassium Channels/antagonists & inhibitors , Potassium Channels/genetics , Potassium Channels/physiology
2.
Indian J Exp Biol ; 2007 Feb; 45(2): 185-93
Article in English | IMSEAR | ID: sea-55654

ABSTRACT

Isolated goat detrusor muscle exhibited spontaneous contractility with an irregular amplitude and frequency. The spontaneity of detrusor muscle exhibited a mean amplitude as 11.99 +/- 0.83 mm and frequency as 1.37 +/- 0.16/min. KATP-channel openers namely, cromakalim or pinacidil (10(-7) - 10(-4) M) added cumulatively, elicited a concentration-related inhibition of both amplitude and rate of spontaneous contractions. The mean IC50 values for both amplitude and frequency for cromakalim were 3.3 x 10(-6) M and 2.9 x 10(-6) M, respectively; and for pinacidil were 2.0 x 10(-5) M and 1.5 x 10(-5) M, respectively. Glibenclamide, a KATP-channel blocker inhibited the cromakalim-induced concentration-related relaxation of spontaneous contractions with a significant increase in its mean IC50. ACh-induced concentration-related contractile response was inhibited in the presence of either cromakalim (10(-4) M) or pinacidil (10(-4) M). The mean EC50 value of ACh, in the presence of cromakalim (2.5 x 10(-3) M) was significantly increased as compared to the control (1.2 x 10(-6) M). In the presence of glibenclamide (10(-5) M) the inhibitory effect of cromakalim was significantly reduced with consequent decrease in the EC50 value (1.9 x 10(-5) M). Application of EFS (30 V and 5 ms) on goat urinary bladder strips at 1, 2, 5, 10, 20 and 30 Hz elicited frequency-related contractile responses. Both cromakalim and pinacidil caused a rightward shift in the frequency-related contractile response curve with significant increase in the mean EF25 and EF50 values, respectively. In the presence of glibenclamide (10(-4) M), the frequency-related inhibitory response curve was shifted to left with significant (P < 0.001) increase in the mean EF25, EF50 and EF75. The present results suggest that in the goat detrusor muscle, agonist and EFS-induced contractile responses were more potently inhibited by cromakalim than pinacidil with activation of glibenclamide sensitive KATP channels.


Subject(s)
Acetylcholine/pharmacology , Animals , Atropine/pharmacology , Cholinergic Agents/pharmacology , Cromakalim/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , Female , Glyburide/pharmacology , Goats/physiology , Male , Muscarinic Antagonists/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/physiology , Pinacidil/pharmacology , Potassium Channel Blockers/pharmacology , Potassium Channels/antagonists & inhibitors , Urinary Bladder/drug effects
3.
Indian Heart J ; 1998 Mar-Apr; 50(2): 173-8
Article in English | IMSEAR | ID: sea-4662

ABSTRACT

The haemodynamic effects of nicorandil, a new balanced vasodilator exhibiting nitrate-like as well as potassium-channel opening activity in patients with chronic severe valvular lesions have not been reported. We studied the acute effect of nicorandil on haemodynamics in 12 stable patients (6 males, 6 females; mean age 23.5 +/- 4.6 years) with chronic severe valvular regurgitation (8 mitral, 4 aortic). All patients were studied in resting, supine and fasting states. All cardioactive drugs were withdrawn five days prior to the study. Intra-arterial line was placed and thermodilution catheter was positioned in the pulmonary artery. Haemodynamic parameters recorded at baseline and at 30, 60, 90 and 120 minutes following a single oral dose of 20 mg nicorandil revealed no significant change in the heart rate while systemic pressures showed a small decline (p < 0.05). There was significant reduction in systolic, diastolic and mean pulmonary artery pressures (p < 0.001). The mean cardiac index increased from 3.16 L/min/m2 at baseline to 3.77 L/min/m2 at 60 minutes. Both the pulmonary and systemic vascular resistance indices reduced significantly, the peak fall being 18 percent and 29 percent, respectively. Maximal changes were observed at 60 to 90 minutes following administration of nicorandil. No adverse effect of nicorandil occurred during the study. We conclude that nicorandil has a favourable acute haemodynamic effect in patients with chronic severe valve regurgitation. Its long-term use in valvular lesions should be explored further.


Subject(s)
Administration, Oral , Adolescent , Adult , Aortic Valve Insufficiency/drug therapy , Chronic Disease , Female , Follow-Up Studies , Hemodynamics/drug effects , Humans , Male , Mitral Valve Insufficiency/drug therapy , Niacinamide/administration & dosage , Nicorandil , Potassium Channels/antagonists & inhibitors , Rheumatic Heart Disease/complications , Treatment Outcome , Vasodilator Agents/administration & dosage , Ventricular Dysfunction, Left/prevention & control
5.
Indian J Physiol Pharmacol ; 1995 Apr; 39(2): 140-4
Article in English | IMSEAR | ID: sea-107677

ABSTRACT

The present investigation was undertaken to study the effects of K+ channel openers in the relaxant responses to various agonists in estrogen primed rat uterus. Adrenaline and isoprenaline produced a dose-dependent relaxation in the estrogen primed rat uterus. The relaxant responses were found to be significantly potentiated when the preparations were exposed to PSS devoid of calcium. The responses to isoprenaline were found to be greater in the preparations depolarized with 40 mM KCl instead of 80 mM KCl. KCl failed to produce any contractile effect in the presence of D-600. Further, the addition of D-600 completely relaxed the KCl depolarized rat uterus. Pinacidil and cromakalim failed to relax 80 mM KCl depolarized rat uterus. However, they produced dose-dependent relaxation in the preparations depolarized with 40 mM KCl. The relaxant responses to pinacidil and cromakalim were competitively blocked by procaine. However, they were not altered by either propranolol or cimetidine. The relaxant responses to isoprenaline and histamine were found to be potentiated by pinacidil and cromakalim. These results indicate that in rat uterus in addition to adenylate cyclase c-AMP, potassium channels are also involved in the relaxant responses to isoprenaline and histamine.


Subject(s)
Animals , Benzopyrans/pharmacology , Calcium/metabolism , Cromakalim , Dose-Response Relationship, Drug , Epinephrine/administration & dosage , Estrogens/administration & dosage , Female , Guanidines/pharmacology , Histamine/pharmacology , Isoproterenol/administration & dosage , Muscle Relaxation , Muscle, Smooth/drug effects , Pinacidil , Potassium Channels/antagonists & inhibitors , Potassium Chloride/pharmacology , Pyrroles/pharmacology , Rats , Rats, Wistar , Uterine Contraction/drug effects , Uterus/drug effects , Vasodilator Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL